The Colorado BioScience Association (CBSA) has released winners of its 2006 Awards Program. The announcement is made by Denise Brown, CBSA Executive Director, who says the CBSA awards program honors those individuals and companies making a significant difference to Colorado’s vibrant bioscience industry in 2006. Presentation of the awards occurs Thursday evening, August 24, at [...]

• 116http://clsdf.com/2006/08/and-the-envelope-please%e2%80%a6/And+The+Envelope+Please%E2%80%A62006-08-22+15%3A47%3A00admin

Broomfield, CO based Accera, Inc., a drug development company focused on Alzheimer’s disease and related neurodegenerative diseases, announced it has recently closed a Series B financing of $7.5M led by returning investors Inventages Venture Capital, POSCO BioVentures and several unnamed private investors. In 2004 Accera closed their $6M Series A round. Based upon their Neuron [...]

• 115http://clsdf.com/2006/08/accera-inc-closes-7-5m-series-b/Accera%2C+Inc.+Closes+%247.5M+Series+B2006-08-18+17%3A12%3A00admin

Sirna Therapeutics, Inc. (Nasdaq: RNAI), reported the final results from its completed Phase I trial for Sirna-027, a novel therapeutic for age-related macular degeneration (AMD). The Phase I study evaluated the safety, tolerability, and biological effect of single-ascending doses of Sirna-027 in patients with AMD. A total of 26 patients with active disease were enrolled [...]

• 114http://clsdf.com/2006/08/move-over-macugen-visudyne-lucentis/Move+Over+Macugen%2C+Visudyne+%26amp%3B+Lucentis%3F2006-08-13+16%3A59%3A00admin

Taligen Therapeutics, Inc. announced that it has successfully attained the development milestone required to trigger the funding of the second tranche of its Series A Preferred financing. The $3.75M Series A is led by Sanderling Ventures, Tango and High Country Venture. The milestone was demonstrated in vivo efficacy of its lead compound TA106. TA106 is [...]

• 113http://clsdf.com/2006/08/taligen-therapeutics-meeting-milestones/Taligen+Therapeutics%3A+Meeting+Milestones2006-08-04+18%3A07%3A00admin

The accelerating building growth at Fitzsimons is unambiguous, even from a distance, thanks to the numerous towering cranes stretching high into the beautiful Colorado sky. Fitzsimons though is more than the CU Health Science Center and variety of hospitals (including the University of Colorado Hospital, the Anschutz Cancer Pavilion, the Barbara Davis Center for Childhood [...]

• 112http://clsdf.com/2006/08/fitz-bioscience-east-open-occupied/Fitz%3A+Bioscience+East+Open+%26amp%3B+Occupied2006-08-03+14%3A51%3A00admin